Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-γ receptor β-chain)

Blood

Volumn 88, Issue 4, 1996, Pages 1383-1389

  Dummer, Reinhard ^a   Heald, Peter W ^b   Nestle, Frank O ^b   Ludwig, Elisabeth ^b   Laine, Elisabeth ^b   Hemmi, Silvio ^b   Burg, Günter ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACCESSORY FACTOR 1; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERFERON RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; IFNGR2 PROTEIN, HUMAN; MESSENGER RNA; PRIMER DNA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELPER CELL; HUMAN; HUMAN CELL; MEMORY CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEZARY SYNDROME; CELL CLONE; CELL CULTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOPHENOTYPING; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; OLIGONUCLEOTIDE PROBE; PATHOPHYSIOLOGY; PHYSIOLOGY; TH2 CELL;

BASE SEQUENCE; CLONE CELLS; CYTOKINES; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPHENOTYPING; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE PROBES; RECEPTORS, INTERFERON; RNA, MESSENGER; SEZARY SYNDROME; TH2 CELLS; TUMOR CELLS, CULTURED;

EID: 0029666161     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.4.1383.bloodjournal8841383     Document Type: Article

References (42)

1. Willemze R, van Vloten WA, Hermans J, Damsteeg MJ, Meijer CJ: Diagnostic criteria in Sezary's syndrome: A multiparameter study of peripheral blood lymphocytes in 32 patients with erythroderma. J Invest Dermatol 81:392, 1983
2. +). J Invest Dermatol 93:413, 1989
3. Geib A, Smoiler B, Warnke R, Picker L: Lymphocytes infiltrating primary cutaneous neoplasms selectively express the cutaneous lymphocyte-associated antigen (CLA). Am J Pathol 142:1556, 1993
4. Heald PW, Yan SL, Edelson RL, Tigelaar R, Picker LJ: Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 101:222, 1993
5. Venencie PY, Winkelmann RK, Friedman SJ, Kyle RA, Puissant A: Monoclonal gammopathy and mycosis fungoides. J Am Acad Dermatol 11:576, 1984
6. van der Putte SCJ, Toonstra J, van Wichen DF, van Unnik JAM, van Vloten W: Aberrant immunophenotype in mycosis fungoides. Arch Dermatol 124:373, 1988
7. Laroche L, Kaiserlian D: Decreased natural-killer cell activity in cutaneous T-cell lymphomas. N Engl J Med 308:101, 1983
8. Dummer R, Nestle F, Wiede J, Schäfer E, Röger J, Erhard H, Hefner H, Burg G: Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas. Eur J Dermatol 1:135, 1991
9. Dummer R, Kohl O, Gillisson J, Kägi M, Burg G: Peripheral blood mononuclear cells in non-leukemic cutaneous T-cell lymphoma patients: Reduced proliferation and preferential secretion of a T helper 2 like cytokine pattern on stimulation. Arch Dermatol 129:433, 1993
10. Nickoloff BJ, Griffiths CEM, Baadsgaard O, Voorhees JJ, Hanson CA, Cooper KD: Markedly diminished epidermal keratinocyte expression of intercellular adhesion molecule-1 (ICAM-1) in Sezary syndrome. JAMA 261:2217, 1989
11. Vowels B, Cassin M, Vonderheid E, Rook A: Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99:90, 1992
12. Saed G, Fivenson DP, Naidu Y, Nickoloff BJ: Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile. J Invest Dermatol 103:29, 1994
13. Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, Rook AH: Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 103:669, 1994
14. Wood GS, Haeffner AC, Dummer R, Crooks C: Molecular biology techniques for the diagnosis of CTCL. Dermatol Clin 12:231, 1994
15. Dunn DA, Gadenne AS, Simha S, Lerner EA, Bigby M, Bleicher PA: T-cell receptor V beta expression in normal human skin. Proc Natl Acad Sci USA 90:1267, 1993
16. Gilks CB, Ho VC, Gascoyne RD, Ellison DJ: T-cell receptor variable region gene expression in cutaneous T-cell lymphomas. J Cutan Pathol 19:21, 1992
17. O'Grady J, Krajewski AS, Ramage EF: Demonstration of clonality in T-cell lymphoma using an anti-T-cell receptor variable region antibody panel. Histopathology 17:553, 1990
18. Potoczna N, Boencke W-H, Nestle FO, Küenzlen C, Sterry W, Burg G, Dummer R: T-cell receptor beta variable region usage in cutaneous T-cell lymphomas in comparison to normal and eczematous skin. J Cutan Pathol (in press)
19. Hemmi S, Bohni R, Stark G, Di Marco F, Aguet M: A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells. Cell 76:803, 1994
20. Pernis A, Gupta S, Gollob KJ, Garfein E, Coffman RL, Schindler C, Rothman P: Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells. Science 269:245, 1995
21. Buechner SA, Winkelmann RK: Pre-Sezary erythroderma evolving to Sezary syndrome. A report of seven cases. Arch Dermatol 119:285, 1983
22. Abel EA, Wood GS, Hoppe RT: Mycosis fungoides: Clinical and histologic features, staging, evaluation, and approach to treatment. CA Cancer J Clin 43:93, 1993
23. Heald PW, Yan SL, Edelson R: Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. Arch Dermatol 130:198, 1994
24. Bunn PA Jr, Lamberg SI: Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas. Cancer Treat Rep 63:725, 1979
25. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219, 1984
26. Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, deVries JE, Roncarolo MG, Mosmann TR, Moore KW: Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88:1172, 1991
27. Butch AW, Chung GH, Hoffmann JW, Nahm MH: Cytokine expression by germinal center cells. J Immunol 150:39, 1993
28. Altschul S, Gish W, Miller W, Myers E, Lipman D: Basic local alignment search tool. J Mol Biol 215:403, 1990
29. Burg G, Dummer R, Kerl H: Classification of cutaneous lymphomas. Derm Clin 12:213, 1994
30. Saed G, Fivenson D, Nickoloff B: Th2 cytokine profile in cutaneous T-cell lymphoma-Reply. J Invest Dermatol 105:856, 1995 (letter)
31. Lessin S, Vowels B, Rook A: Th2 cytokine profile in cutaneous T-cell lymphoma. J Invest Dermatol 105:855, 1995 (letter)
32. Vonderheid EC, Bigler RD, Greenberg AS, Neukum SJ, Micaily B: Extracorporeal photopheresis and recombinant interferon alfa 2b in Sezary syndrome. Use of dual marker labeling to monitor therapeutic response. Am J Clin Oncol 17:255, 1994
33. Peris K, Niedermeyer H, Cerroni L, Radaskiewicz T, Chimenti S, Höfler H: Detection of Epstein-Barr virus genome in primary cutaneous T and B cell lymphomas and pseudolymphomas. Arch Dermatol Res 286:364, 1994
34. Hsu DH, de Waal Malefyt R, Fiorentino DF, Dang MN, Vieira P, de Vries J, Spits H, Mosmann TR, Moore KW: Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250:830, 1990
35. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348, 1986
36. Mosmann TR, Moore KW: The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol Today 12:49, 1991
37. Romagnani S: Human TH1 and TH2 subsets: Doubt no more, Immunol Today 12:256, 1991
38. Romagnani S: Human TH1 and TH2 subsets: Regulation of differentiation and role in protection and immunopathology. Int Arch Allergy Immunol 98:279, 1992
39. Dummer R, Laine E, Döbbeling U, Burg G, Nestle F: T-cell relevant cytokines during extracorporeal photopheresis (ECP) in Sézary syndrome, detected by a newly developed PCR-ELISA technique. J Invest Dermatol 104:653, 1995 (abstr)
40. Rook AH, Kubin M, Cassin M, Vonderheid EC, Vowels BR, Wolfe JT, Wolf SF, Singh A, Trinchieri G, Lessin SR: IL-12 reverses cytokine and immune abnormalities in Sezary syndrome. J Immunol 154:1491, 1995
41. Marsters SA, Pennica D, Bach E, Schreiber RD, Ashkenazi A: Interferon gamma signals via a high-affinity multisubunit receptor complex that contains two types of polypeptide chain. Proc Natl Acad Sci USA 92:5401, 1995
42. Bach E, Szabo S, Dighe A, Ashkenazi A, Aguet M, Murphy K, Schreiber R: Ligand-induced autoregulation of IFN-gamma receptor beta chain expression in T helper subsets. Science 270:1215, 1995